Search

Babuta, Mrigya, and Gyongyi Szabo. 2022. “Extracellular Vesicles in Inflammation: Focus on the MicroRNA Cargo of EVs in Modulation of Liver Diseases.”. Journal of Leukocyte Biology 111 (1): 75-92.

Ribeiro, Marcelle de Carvalho, and Gyongyi Szabo. 2022. “Role of the Inflammasome in Liver Disease.”. Annual Review of Pathology 17: 345-65.

Szabo, Gyongyi, Mark Thursz, and Vijay H Shah. 2022. “Therapeutic Advances in Alcohol-Associated Hepatitis.”. Journal of Hepatology 76 (6): 1279-90.

Cho, Yeonhee, Radhika Joshi, Patrick Lowe, Christopher Copeland, Marcelle Ribeiro, Caroline Morel, Donna Catalano, and Gyongyi Szabo. 2022. “Granulocyte Colony-Stimulating Factor Attenuates Liver Damage by M2 Macrophage Polarization and Hepatocyte Proliferation in Alcoholic Hepatitis in Mice.”. Hepatology Communications 6 (9): 2322-39.

Pita-Juárez, Yered, Dimitra Karagkouni, Nikolaos Kalavros, Johannes C Melms, Sebastian Niezen, Toni M Delorey, Adam L Essene, et al. 2022. “A Single-Nucleus and Spatial Transcriptomic Atlas of the COVID-19 Liver Reveals Topological, Functional, and Regenerative Organ Disruption in Patients.”. BioRxiv : The Preprint Server for Biology.

Vatsalya, Vatsalya, Wenke Feng, Maiying Kong, Huirong Hu, Gyongyi Szabo, Arthur McCullough, Srinivasan Dasarathy, et al. 2023. “The Beneficial Effects of Lactobacillus GG Therapy on Liver and Drinking Assessments in Patients With Moderate Alcohol-Associated Hepatitis.”. The American Journal of Gastroenterology 118 (8): 1457-60.

Ribeiro, Marcelle de Carvalho, Yeonhee Cho, Jeeval Mehta, Xiaojing Wang, Mrigya Babuta, Christopher Copeland, Hosni Hussein, Donna Catalano, Yanbo Wang, and Gyongyi Szabo. 2023. “Protective Role of CGAS in NASH Is Related to the Maintenance of Intestinal Homeostasis.”. Liver International : Official Journal of the International Association for the Study of the Liver 43 (9): 1937-49.

Bala, Shashi, Yuan Zhuang, Prashanth Thevkar Nagesh, Donna Catalano, Adam Zivny, Yanbo Wang, Jun Xie, Guangping Gao, and Gyongyi Szabo. 2023. “Therapeutic Inhibition of MiR-155 Attenuates Liver Fibrosis via STAT3 Signaling.”. Molecular Therapy. Nucleic Acids 33: 413-27.

Hassanein, Tarek, Craig J McClain, Vatsalya Vatsalya, Lance L Stein, Steven L Flamm, Paul Martin, Matthew C Cave, et al. 2024. “Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated Hepatitis.”. The American Journal of Gastroenterology 119 (1): 107-15.

Ribeiro, Marcelle de Carvalho, Mrigya Babuta, and Gyongyi Szabo. 2024. “Reply: Alcohol-Induced Extracellular ASC Specks Perpetuate Liver Inflammation and Damage in Alcohol-Associated Hepatitis Even After Alcohol Cessation.”. Hepatology (Baltimore, Md.) 79 (2): E28-E29.